New Novartis Flea And Tick Products To Hit Market

Novartis to offer new flea and tick products this summer.

Novartis Animal Health US, Inc. today launched new EPA-approved flea and tick control products for dogs and cats to be available through U.S. veterinarians this summer. Parastar for dogs and EasySpot for cats are species-specific formulations of fipronil, a flea and tick adulticide.

Parastar and EasySpot topicals are designed to offer fast-acting, waterproof, 30-day control of fleas, chewing lice and all major ticks, including those that may carry Lyme disease. Parastar is made especially for dogs and puppies 8 weeks of age and older. EasySpot is designed exclusively for cats and kittens 8 weeks of age and older.

“The Novartis family of parasiticides is defined by best-in-class medicine, so Parastar and EasySpot fit perfectly,” says Jason Drake, DVM, director of professional services at Novartis. “Together with the heartworm preventive medicine that veterinarians choose most for their own dogs and the only systemic flea product with an insect growth regulator, the proven power of fipronil found in Parastar and EasySpot is a natural addition to the family.”

Parastar and EasySpot are registered in more than 40 states. Visit ParaStarPet.com or EasySpotPet.com  for more information.

<Home>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.